HIV

News

J&J builds case for HIV vaccine ahead of pivotal trial reado...

Johnson & Johnson has moved a step closer to the goal of developing a vaccine that can help prevent HIV infection, thanks to positive data from a phase 1/2a trial.

News

ViiV redeems voucher for fast FDA review of HIV combination

ViiV Healthcare has applied for a fast US review of its single-tablet, two drug HIV drug regimen of dolutegravir and lamivudine.

News

MPs call for NHS funding for HIV prevention drug

Leading UK politicians have called for an HIV prevention drug to be made available across the NHS, after a court ruling paved the way for cheap generic versions of Gilead’s Truvada.

News

Truvada ruling could allow cheap HIV prevention in the UK

Cheap copies of Gilead’s HIV drug Truvada, which can also be used to reduce the risk of people becoming infected, could be available in the UK following a court ruling.

News

FDA approves Merck’s Delstrigo and Pifeltro for HIV treatmen...

Merck, known as MSD outside the United States and Canada announced that the Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro.

News

HIV drug cuts viral load, boosts immunity in Yale study

A Yale University study has found ibalizumab reduced viral replication and increased the count of immune cells in HIV patients, raising hopes for a new form of treatment for the disease.

J&J builds case for HIV vaccine ahead of pivotal trial reado...

ViiV redeems voucher for fast FDA review of HIV combination

MPs call for NHS funding for HIV prevention drug

Truvada ruling could allow cheap HIV prevention in the UK

FDA approves Merck’s Delstrigo and Pifeltro for HIV treatmen...

HIV drug cuts viral load, boosts immunity in Yale study

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

HIV

Editor's Picks